Caribou Biosciences Files 8-K on Financials and Operations
Ticker: CRBU · Form: 8-K · Filed: Apr 24, 2025 · CIK: 1619856
| Field | Detail |
|---|---|
| Company | Caribou Biosciences, INC. (CRBU) |
| Form Type | 8-K |
| Filed Date | Apr 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, disposal-activities
Related Tickers: CRBU
TL;DR
CRBU filed an 8-K detailing financial results, exit costs, and other events.
AI Summary
On April 24, 2025, Caribou Biosciences, Inc. filed an 8-K report. The filing indicates the company is reporting on its results of operations and financial condition, costs associated with exit or disposal activities, and other events. It also includes financial statements and exhibits.
Why It Matters
This 8-K filing provides investors with crucial updates on Caribou Biosciences' financial health and operational activities, including any restructuring or disposal costs.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can significantly impact a company's stock price, requiring careful investor review.
Key Players & Entities
- Caribou Biosciences, Inc. (company) — Registrant
- 0001619856-25-000023 (filing_id) — Accession Number
- April 24, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Berkeley, California (location) — Principal Executive Offices
FAQ
What specific items are being reported under 'Results of Operations and Financial Condition'?
The filing does not provide specific details on the results of operations and financial condition within the provided text; it only states that this is an item being reported.
Are there any significant costs associated with exit or disposal activities mentioned?
The filing indicates that 'Cost Associated with Exit or Disposal Activities' is an item being reported, but the specific amounts or nature of these costs are not detailed in the provided text.
What are the 'Other Events' that Caribou Biosciences is reporting?
The provided text for the 8-K filing lists 'Other Events' as a reported item but does not specify what these events are.
When was Caribou Biosciences incorporated?
Caribou Biosciences, Inc. was incorporated in Delaware, as stated in the filing.
What is the principal executive office address for Caribou Biosciences?
The principal executive offices of Caribou Biosciences, Inc. are located at 2929 7th Street, Suite 105, Berkeley, California 94710.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 24, 2025 regarding Caribou Biosciences, Inc. (CRBU).